These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS. Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [Abstract] [Full Text] [Related]
4. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]
7. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study. Kobalava ZD, Kotovskaya YV, Villevalde SV, Moiseev VS, ARGUS-2 Study. Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008 [Abstract] [Full Text] [Related]
8. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study. Akram J, Sheikh UE, Mahmood M, Donnelly R. Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463 [Abstract] [Full Text] [Related]
9. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension. Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A. Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517 [Abstract] [Full Text] [Related]
10. [Blood pressure control in hypertensive patients with stable coronary heart disease]. Chamontin B, Beaune J, Cambou JP, Vaisse B, Bonnelye G, Ricard S, Josse L, Gallois H. Arch Mal Coeur Vaiss; 2005 Aug; 98(7-8):795-9. PubMed ID: 16220750 [Abstract] [Full Text] [Related]
13. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M. Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [Abstract] [Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL. Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [Abstract] [Full Text] [Related]
15. Lack of control of high blood pressure and treatment recommendations in Canada. Khan N, Chockalingam A, Campbell NR. Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423 [Abstract] [Full Text] [Related]
16. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH, Burgess ED, Assouline L, Vanjaka A. Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [Abstract] [Full Text] [Related]
17. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000. Al Khaja KA, Sequeira RP. Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299 [Abstract] [Full Text] [Related]
18. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S. Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [Abstract] [Full Text] [Related]